Inflammation and reduced endothelial function in the course of severe acute heart failure

Translational Research

Volumn 157, Issue 3, 2011, Pages 117-127

  Hermansen, Stig E ^a,b   Kalstad, Trine ^b   How, Ole Jakob ^b   Myrmel, Truls ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; LACTIC ACID; N(G),N(G) DIMETHYLARGININE; VASCULAR ADHESION PROTEIN 1;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; BODY PLETHYSMOGRAPH; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEART PERFUSION; HUMAN; LACTATE BLOOD LEVEL; MALE; PERICARDIOTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 79951641313     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2010.12.002     Document Type: Article

References (50)

1. J.S. Hochman Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm Circulation 107 2003 2998 3002 (Pubitemid 36758968)
2. V. Menon, J.N. Slater, H.D. White, L.A. Sleeper, T. Cocke, and J.S. Hochman Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry Am J Med 108 2000 374 380 (Pubitemid 30162955)
3. S. Kohsaka, V. Menon, and A.M. Lowe Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock Arch Intern Med 165 2005 1643 1650 (Pubitemid 41124160)
4. J.S. Hochman, C.E. Buller, and L.A. Sleeper Cardiogenic shock complicating acute myocardial infarction - etiologies, management and outcome: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol 36 2000 1063 1070
5. J.H. Alexander, H.R. Reynolds, and A.L. Stebbins Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial JAMA 297 2007 1657 1666 (Pubitemid 46631624)
6. A. Geppert, A. Dorninger, G. Delle-Karth, G. Zorn, G. Heinz, and K. Huber Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction Crit Care Med 34 2006 2035 2042 (Pubitemid 44305602)
7. A. Geppert, A. Steiner, and G. Zorn Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6 Crit Care Med 30 2002 1987 1994
8. T. Katayama, H. Nakashima, C. Takagi, Y. Honda, S. Suzuki, and K. Yano Predictors of mortality in patients with acute myocardial infarction and cardiogenic shock Circ J 69 2005 83 88 (Pubitemid 40139614)
9. P. Theroux, P.W. Armstrong, and K.W. Mahaffey Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial Eur Heart J 26 2005 1964 1970 (Pubitemid 41435718)
10. M. Debrunner, E. Schuiki, and E. Minder Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock Clin Res Cardiol 97 2008 298 305 (Pubitemid 351725055)
11. R.H. Boger Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond Ann Med 38 2006 126 136
12. M.C. Stuhlinger, R.K. Oka, and E.E. Graf Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine Circulation 108 2003 933 938 (Pubitemid 37048221)
13. M. Ohnishi, A. Wada, and T. Tsutamoto Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure Clin Sci (Lond) 103 Suppl. 48 2002 241S 244S (Pubitemid 35007161)
14. J. Leiper, M. Nandi, and B. Torondel Disruption of methylarginine metabolism impairs vascular homeostasis Nat Med 13 2007 198 203
15. V. Achan, M. Broadhead, and M. Malaki Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase Arterioscler Thromb Vasc Biol 23 2003 1455 1459 (Pubitemid 36994536)
16. S.J. Nicholls, Z. Wang, and R. Koeth Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction Circulation 116 2007 2315 2324 (Pubitemid 350100338)
17. R.J. Nijveldt, T. Teerlink, and B. Van Der Hoven Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality Clin Nutr 22 2003 23 30 (Pubitemid 36193177)
18. M. Saitoh, T. Osanai, and T. Kamada High plasma level of asymmetric dimethylarginine in patients with acutely exacerbated congestive heart failure: role in reduction of plasma nitric oxide level Heart Vessels 18 2003 177 182 (Pubitemid 37258670)
19. C. Duckelmann, F. Mittermayer, D.G. Haider, J. Altenberger, and M. Wolzt Plasma asymmetric dimethylarginine and cardiovascular events in patients with acute decompensated heart failure Trans Res 152 2008 24 30
20. G. Wernovsky, D. Wypij, and R.A. Jonas Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest Circulation 92 1995 2226 2235
21. J.S. Chen, W.J. Ko, and H.Y. Yu Analysis of the outcome for patients experiencing myocardial infarction and cardiopulmonary resuscitation refractory to conventional therapies necessitating extracorporeal life support rescue Crit Care Med 34 2006 950 957
22. J.L. Vincent, R. Moreno, and J. Takala The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine Intensive Care Med 22 1996 707 710
23. M. Dhindsa, S.M. Sommerlad, and A.E. DeVan Interrelationships among noninvasive measures of postischemic macro- and microvascular reactivity J Appl Physiol 105 2008 427 432
24. J.T. Kuvin, A.R. Patel, and K.A. Sliney Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude Am Heart J 146 2003 168 174 (Pubitemid 36851317)
25. A. Nohria, M. Gerhard-Herman, M.A. Creager, S. Hurley, D. Mitra, and P. Ganz Role of nitric oxide in the regulation of digital pulse volume amplitude in humans J Appl Physiol 101 2006 545 548 (Pubitemid 44162364)
26. T.W. Yeo, D.A. Lampah, and R. Gitawati Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria J Exp Med 204 2007 2693 2704 (Pubitemid 350044792)
27. M. Matsumoto, T. Tsujino, and M. Lee-Kawabata Serum interleukin-6 and C-reactive protein are markedly elevated in acute decompensated heart failure patients with left ventricular systolic dysfunction Cytokine 49 2010 264 268
28. I. de Werra, C. Jaccard, and S.B. Corradin Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia Crit Care Med 25 1997 607 613 (Pubitemid 27193972)
29. J.S. Davis, T.W. Yeo, and J.H. Thomas Sepsis-associated microvascular dysfunction measured by peripheral arterial tonometry: an observational study Crit Care 13 2009 R155
30. D. Paparella, T.M. Yau, and E. Young Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update Eur J Cardiothorac Surg 21 2002 232 244 (Pubitemid 34135370)
31. L.A. Kirschenbaum, M.E. Astiz, E.C. Rackow, D.C. Saha, and R. Lin Microvascular response in patients with cardiogenic shock Crit Care Med 28 2000 1290 1294 (Pubitemid 30324495)
32. D.H. Thijssen, P.C. de Groot, M. Kooijman, P. Smits, and M.T. Hopman The sympathetic nervous system contributes to the age-related impairment of flow-mediated dilation of the superficial femoral artery Am J Physiol Heart Circ Physiol 291 2006 H3122 H3129
33. R. Berger, B. Stanek, and M. Hulsmann Effects of endothelin a receptor blockade on endothelial function in patients with chronic heart failure Circulation 103 2001 981 986 (Pubitemid 32183804)
34. J.M. Quayle, M.T. Nelson, and N.B. Standen ATP-sensitive and inwardly rectifying potassium channels in smooth muscle Physiol Rev 77 1997 1165 1232 (Pubitemid 27459582)
35. M.E. Astiz, G.E. DeGent, R.Y. Lin, and E.C. Rackow Microvascular function and rheologic changes in hyperdynamic sepsis Crit Care Med 23 1995 265 271
36. B.R. Clapp, A.D. Hingorani, and R.K. Kharbanda Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress Cardiovasc Res 64 2004 172 178 (Pubitemid 39208934)
37. A.D. Hingorani, J. Cross, and R.K. Kharbanda Acute systemic inflammation impairs endothelium-dependent dilatation in humans Circulation 102 2000 994 999 (Pubitemid 30657515)
38. P.O. Iversen, A. Nicolaysen, K. Kvernebo, H.B. Benestad, and G. Nicolaysen Human cytokines modulate arterial vascular tone via endothelial receptors Pflugers Arch 439 1999 93 100 (Pubitemid 30055512)
39. F. Schulze, R. Maas, R. Freese, E. Schwedhelm, E. Silberhorn, and R.H. Boger Determination of a reference value for N(G), N(G)-dimethyl-L-arginine in 500 subjects Eur J Clin Invest 35 2005 622 626 (Pubitemid 41406726)
40. J.D. Horowitz, and T. Heresztyn An overview of plasma concentrations of asymmetric dimethylarginine (ADMA) in health and disease and in clinical studies: methodological considerations J Chromatogr B Analyt Technol Biomed Life Sci 851 2007 42 50 (Pubitemid 46720137)
41. I. Karu, K. Zilmer, J. Starkopf, and M. Zilmer Changes of plasma asymmetric dimethylarginine levels after coronary artery bypass grafting Scand Cardiovasc J 40 2006 363 367 (Pubitemid 44803889)
42. T. Loukanov, R. Arnold, and J. Gross Endothelin-1 and asymmetric dimethylarginine in children with left-to-right shunt after intracardiac repair Clin Res Cardiol 97 2008 383 388
43. P. Vallance, A. Leone, A. Calver, J. Collier, and S. Moncada Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure Lancet 339 1992 572 575
44. M.J. O'Dwyer, F. Dempsey, V. Crowley, D.P. Leher, R. McManus, and T. Ryan Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study Crit Care 10 2006 R139
45. M.C. Richir, B. Ellger, and T. Teerlink The effect of rosiglitazone on asymmetric dimethylarginine (ADMA) in critically ill patients Pharmacol Res 60 2009 519 524
46. T. Teerlink ADMA metabolism and clearance Vasc Med 10 Suppl. 1 2005 S73 S81
47. R.J. Nijveldt, T. Teerlink, and P.A. van Leeuwen The asymmetrical dimethylarginine (ADMA)-multiple organ failure hypothesis Clin Nutr 22 2003 99 104 (Pubitemid 36193187)
48. A. Ito, P.S. Tsao, S. Adimoolam, M. Kimoto, T. Ogawa, and J.P. Cooke Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase Circulation 99 1999 3092 3095 (Pubitemid 29289071)
49. J. Leiper, J. Murray-Rust, N. McDonald, and P. Vallance S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase Proc Natl Acad Sci U S A 99 2002 13527 13532 (Pubitemid 35215415)
50. S. Ueda, S. Kato, and H. Matsuoka Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase Circ Res 92 2003 226 233 (Pubitemid 36254279)